Neoprobe Corp. Advances Investigational Initiative on RIGScan to Enable More Effective Colon Cancer Surgeries, Article Posted on BeaconEquity.com
Neoprobe (OTCBB: NEOP) announces the centralized European Medicines Agency (EMEA) has provided positive formal responses to Neoprobe’s scientific advice submission regarding RIGScan CR and the pathway to receive a marketing authorization for the drug.
(EMAILWIRE.COM, November 04, 2008 ) DALLAS, Texas - BeaconEquity.com announces the publication of “Neoprobe Corp. Advances Investigational Initiative on RIGScan to Enable More Effective Colon Cancer Surgeries.”
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m - Click on News and Commentary
In the article the author writes:
"For a company focused on developing and commercializing innovative biomedical products, obtaining the best results possible from scientific advice is crucial to the success of an application. … Neoprobe's focus is in improving cancer surgery outcomes by using its market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents.”
Neoprobe‘s RIGScan CR assist surgeons in a more complete removal of colon cancer:
“In clinical trials to date, RIGScan CR, a tumor-specific targeting agent, has alerted surgeons to the existence of additional cancerous tissue, undetectable by traditional diagnostic and intraoperative techniques, thereby enabling more effective colon cancer surgeries.”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m - Click on News and Commentary
In the article the author writes:
"For a company focused on developing and commercializing innovative biomedical products, obtaining the best results possible from scientific advice is crucial to the success of an application. … Neoprobe's focus is in improving cancer surgery outcomes by using its market-leading gamma detection devices in combination with radiopharmaceutical agents also referred to as “tracing” or “targeting” agents.”
Neoprobe‘s RIGScan CR assist surgeons in a more complete removal of colon cancer:
“In clinical trials to date, RIGScan CR, a tumor-specific targeting agent, has alerted surgeons to the existence of additional cancerous tissue, undetectable by traditional diagnostic and intraoperative techniques, thereby enabling more effective colon cancer surgeries.”
To read the entire article visit http://www.beaconequity.com/m – Click on News and Commentary
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting:
http://www.beaconequity.com/m
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
Contact Information:
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Beacon Equity Research
Jeff Bishop
Tel: (469)-252-3505
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Press Release Keywords:
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, neoprobe corp.
stock market, investing, investment ideas, market activity, small caps, micro caps, search engines, technology stocks, blue chips, marketing solutions, beaconequity.com, neoprobe corp.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |